C-CAMP announces next-generation tripartite Indo-European collaboration to fight AMR

November 01, 2023 | Wednesday | News

Tripartite agreement welcomes a new entrant- Swissnex in India

Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP), an initiative supported by the Department of Biotechnology, has announced a next-generation tripartite Indo-European collaboration to address the grave challenges posed by Antimicrobial Resistance (AMR), with science, innovation, policy, and stewardship. This tripartite agreement welcomes a new entrant, Swissnex in India, the Swiss science and technology consulate part of a Swiss global network connecting Switzerland and the world in education, research, and innovation, as part of the WAAH! Accelerator which was originally signed between the Dutch Embassy and C-CAMP in December 2022.

The WAAH! Accelerator is working towards emphasising co-creation and co-development of new technologies in Water, Agriculture, Animal, and Human Health towards fulfilling the One Health approach to address AMR. This Accelerator was set up as a C-CAMP partnership with NADP (Netherlands Antibiotic Development Platform) and AMR Global, both Netherlands-based organisations. With Swissnex in India joining this programme, this agreement will not only encourage path-breaking science but also prioritise faster impact on-field nationally and globally.

This tripartite agreement was recently announced at the C-CAMP premises by its Director-CEO Dr Taslimarif Saiyed, and Jonas Brunschwig CEO, Consul General, Swissnex in India at an exclusive event during the Indo-Swiss AMR Innovation Dialogue that brought selected AMR innovators from C-CAMP portfolio, and C-CAMP’s international partners to the same table as high-level delegates and policymakers from the Indian, Swiss and Dutch scientific ecosystems.

The partners have prioritised problem areas within AMR that they will address in a phase-wise manner. As a start, the WAAH! plans to roll out a global AMR challenge in early 2024 after a detailed needs-assessment exercise by the stakeholders, and identification of a subset of AMR challenges that can be addressed with innovations, while efficiently leveraging the respective innovation networks.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy